News Releases

Date Title and Summary Additional Formats
Toggle Summary Avid Bioservices Reports Financial Results for First Quarter Fiscal 2019 and Recent Developments
-- F iscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed -- -- Multiple Projects Advanced During the Quarter -- -- Initiated Operations of New Process Development Laboratories -- TUSTIN, Calif. , Sept. 10, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc.
View HTML
Toggle Summary Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
TUSTIN, Calif. , Sept. 05, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and
View HTML
Toggle Summary Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2019 After Market Close on September 10, 2018
TUSTIN, Calif. , Sept. 04, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and
View HTML
Toggle Summary Avid Bioservices to Present at Upcoming Investor Conferences
TUSTIN, Calif. , Aug. 29, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology
View HTML
Toggle Summary Avid Bioservices to Exhibit at the 2018 BioProcess International Conference & Exhibition
-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- TUSTIN, Calif. , Aug. 28, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc.
View HTML
Toggle Summary Avid Bioservices to Exhibit at the Bioprocessing Summit 2018
Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity TUSTIN, Calif. , Aug. 08, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc.
View HTML
Toggle Summary Avid Bioservices Announces Appointment of Daniel Hart as Chief Financial Officer
-- Senior Executive with Extensive Financial Leadership Experience Further Strengthens Management Team; Company Also Adds Senior Director of Business Development for Western Region to Support Client Acquisition Efforts -- TUSTIN, Calif. , July 17, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc.
View HTML
Toggle Summary Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2018 and Recent Developments
-- Company Records Fiscal Year 2018 Revenue of $53.6 Million -- -- Committed Backlog Increases to $57.8 Million (ASC 605) -- -- Customer Base Expanded and Diversified -- -- Key Appointments Strengthen CDMO Leadership Team -- TUSTIN, Calif. , July 16, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc.
View HTML
Toggle Summary Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2018 After Market Close on July 16, 2018
TUSTIN, Calif. , July 09, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and
View HTML
Toggle Summary Avid Bioservices Added to Russell 3000® Index and Russell 2000® Index
TUSTIN, Calif. , June 25, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology
View HTML
Toggle Summary Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
TUSTIN, Calif. , June 06, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology
View HTML
Toggle Summary Avid Bioservices to Participate at BIO International Convention 2018
-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- -- Company's Newly Appointed Director of Business Development for East Coast to Join Team at BIO 2018 --
View HTML
Toggle Summary Avid Bioservices to Participate at BIO International Convention 2018
-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- -- Company’s Newly Appointed Director of Business Development for East Coast to Join Team at BIO 2018 --
View HTML
Toggle Summary Avid Bioservices Announces Appointment of Magnus Schroeder, Ph.D., as Vice President of Process Sciences
-- Addition of Senior Executive with Significant Process Science Experience Supports Company's Efforts to Expand and Enhance Process Development Capabilities -- TUSTIN, Calif. , May 08, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development
View HTML
Toggle Summary Avid Bioservices Provides Update on Ongoing Expansion of Process Development Capabilities and Laboratory Infrastructure
E nhancements Support New Customer Acquisition Efforts, Highlighted by Recent Signing of Three New Process Development and Manufacturing Agreements TUSTIN, Calif. , April 24, 2018 (GLOBE NEWSWIRE) --   Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and
View HTML